Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2015 - 2026)
Insight Molecular Diagnostics' (IMDX) quarterly Other Working Capital Changes came in at -$83000.0 in Q1 2026, down 197.65% year-on-year from $85000.0 in Q1 2025, and down 315.0% quarter-over-quarter from -$20000.0 in Q4 2025.
Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has disclosed Other Working Capital Changes across 12 years of filings, most recently posting -$83000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$83000.0, down 197.65% year-over-year; the trailing twelve-month figure through Mar 2026 was -$310000.0 (down 15.67% YoY), and the FY2025 annual result was -$142000.0, up 51.2% from the prior year.
- Other Working Capital Changes came in at -$83000.0 for Q1 2026 at Insight Molecular Diagnostics, down from -$20000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $795000.0 in Q3 2022 to a low of -$514000.0 in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$46000.0 (2022), against an average of -$24500.0.
- Peak annual rise in Other Working Capital Changes reached 1104.55% in 2022, while the deepest fall reached 2236.36% in 2022.
- Insight Molecular Diagnostics' Other Working Capital Changes stood at -$514000.0 in 2022, then surged by 87.55% to -$64000.0 in 2023, then slumped by 162.5% to -$168000.0 in 2024, then jumped by 88.1% to -$20000.0 in 2025, then plunged by 315.0% to -$83000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$83000.0 (Q1 2026), -$20000.0 (Q4 2025), and -$57000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83,000.00 |
| Mar 31, 2026 | -83,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Sep 30, 2025 | -57,000.00 |
| Sep 30, 2025 | -57,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Jun 30, 2024 | -185,000.00 |
| Jun 30, 2024 | -185,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | -64,000.00 |
| Dec 31, 2023 | -64,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Sep 30, 2023 | 75,000.00 |